Pharmacoprotective influences on different links of the mechanism underlying 6-hydroxydopamine-induced degeneration of nigro-striatal dopaminergic neurons

By Talanov S.   Oleshko N.   Tkachenko M.   Sagach V.  

Neurophysiology, Vol. 38, Iss. 2, 2006-03 ,pp. : 128-133

Springer Publishing Company

Access to resources Recommend Favorite

In Vivo Extracellular Recording of Striatal Neurons in the Awake Rat Following Unilateral 6-Hydroxydopamine Lesions

By Chen M.-T.   Morales M.   Woodward D.J.   Hoffer B.J.   Janak P.H.  

Experimental Neurology, Vol. 171, Iss. 1, 2001-09 ,pp. : 72-83

Elsevier

Access to resources Recommend Favorite

Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson’s Disease

By Cordellini Marcela   Piazzetta Giovana   Pinto Karin   Delattre Ana   Matheussi Francesca   Carolino Ruither   Szawka Raphael   Anselmo-Franci Janete   Ferraz Anete  

Neurochemical Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 955-961

Springer Publishing Company

Access to resources Recommend Favorite

Ether - à - go - go 1 (Eag1) Potassium Channel Expression in Dopaminergic Neurons of Basal Ganglia is Modulated by 6-Hydroxydopamine Lesion

By Ferreira N.  

Neurotoxicity Research, Vol. 21, Iss. 3, 2012-04 ,pp. : 317-333

Springer Publishing Company

Access to resources Recommend Favorite

Cyclosporin A Attenuates the Decrease in Tyrosine Hydroxylase Immunoreactivity in Nigrostriatal Dopaminergic Neurons and in Striatal Dopamine Content in Rats with Intrastriatal Injection of 6-Hydroxydopamine

By Matsuura K.   Makino H.   Ogawa N.  

Experimental Neurology, Vol. 146, Iss. 2, 1997-08 ,pp. : 526-535

Elsevier

Access to resources Recommend Favorite